Log In
Print
BCIQ
Print
Print this Print this
 

Captisol-enabled topiramate injection

Also known as: topiramate

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionCaptisol-enabled topiramate injection
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSeizures
Indication DetailsTreat epileptic seizures; Treat partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate
Regulatory Designation

U.S. - Orphan Drug (Treat partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate)

Partner

CURx Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$21.1M

$0.1M

$21.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today